- Home
- BCTX vs BEAT Comparison
BCTX vs BEAT Comparison
Compare BCTX & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCTX | BEAT |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6M | 27.7M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BCTX | BEAT |
|---|---|---|
| Price | $3.98 | $0.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $40.00 | $5.63 |
| AVG Volume (30 Days) | 193.1K | ★ 408.2K |
| Earning Date | 06-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.07 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $380.95 | $315.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.60 | $0.47 |
| 52 Week High | $14.68 | $4.00 |
Technical Indicators
Market Signals| Indicator | BCTX | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 42.30 |
| Support Level | $3.66 | N/A |
| Resistance Level | $3.74 | $0.63 |
| Average True Range (ATR) | 0.26 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 37.20 | 14.86 |
Price Performance
Historical ComparisonAbout BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.